Search

everythinglearnresearchcommunity

for

Search:↓

Anticancer drugs are increasingly found in surface waters, and their long-term environmental effects are not well understood, requiring better testing methods.

The guidelines advise against using testosterone and DHEA in women for most conditions due to safety and effectiveness concerns, but suggest considering testosterone for postmenopausal women with low sexual desire.

Lifestyle changes can improve body composition, excess male hormone levels, and insulin resistance in women with PCOS.

Tributyltin exposure causes sex changes, sterilization, and decline in the snail Ocinebrina aciculata, risking its extinction.

Hair loss linked to higher heart disease risk in both men and women.

Different types of PCOS have different levels of metabolic problems, with the most severe type showing the highest disturbances.

Metformin has limited effectiveness for improving PCOS symptoms and lacks clear benefits, needing more research to confirm its efficacy.

Hidradenitis suppurativa improves with antiandrogen therapy.

Finasteride for hair loss may cause long-lasting side effects like impotence and low libido, but trials lack proper safety reporting.

Negative expectations can cause adverse effects in patients even without active treatment, and managing this nocebo effect involves better communication and patient-clinician relationships.

Finger length ratios are not linked to the number of specific gene repeats affecting testosterone sensitivity.

Genetics play a role in acne, but how exactly they contribute is not fully understood.

Finasteride and CPA-EE2 equally reduce hirsutism, but affect hormone levels differently.

Minoxidil effectively treats female pattern hair loss.

Women with polycystic ovary syndrome tend to have a longer anogenital distance.

Spironolactone is better than placebo for reducing excessive hair growth in women, but its effectiveness for acne is unclear due to small study sizes.

Men with testicular cancer were less likely to experience baldness and severe acne.

Taking spironolactone and linestrenol for androgen excess can lead to lower bone density in young women.

The nafarelin test can reliably distinguish between gonadotropin deficiency and delayed puberty in teenage boys.

DHEA may help with sexual function when used intravaginally by menopausal women but is similar to hormone therapy in other aspects and might cause more side effects like acne and hair loss.

Topical minoxidil helps treat female pattern hair loss, but more research needed for other treatments.

High energy boosts root hair growth in plants, while low energy stops it.

Men with male pattern baldness have a higher risk of dying from prostate cancer.

Nanog gene boosts stem cells, helps hair growth, and may treat hair loss.

Vitamin D receptor helps control hair growth genes in skin cells.

Most doctors know the thrombosis risk with Cyproterone/Ethinylestradiol, but some lack details on less common risks and patient instructions; educational materials are underused but useful.

Testosterone therapy seems safe for short-term use in postmenopausal women with low sexual desire, but more research on long-term effects is needed.

Asian patients with Frontal Fibrosing Alopecia often lose eyebrow hair and respond well to combined antiandrogen or antimalarial and topical treatments.

A 17-year-old female with adrenogenital syndrome produces very high levels of androgens, which prevent complete feminization despite high estrogen doses.

A specific thyroid hormone resistance mutation may be linked to different types of hair loss.